Ibolya Csecs
Clinical FellowAbout
Research
Publications
2025
A series of hydroxychloroquine-associated cardiotoxicity presenting with heart failure
Nazarenko N, Maliha M, Parker M, Borkowski P, Csecs I, Tauras J, Julia Shin J, Pullman J, Sims D, Rochlani Y. A series of hydroxychloroquine-associated cardiotoxicity presenting with heart failure. Annals Of Medicine And Surgery 2025, 87: 1334-1340. DOI: 10.1097/ms9.0000000000002997.Peer-Reviewed Original ResearchSystemic lupus erythematosusHCQ useHeart failureCardiac abnormalitiesCardiac magnetic resonance imagingDose-dependent complicationsRheumatoid arthritisCases of SLE patientsDiscontinuation of hydroxychloroquineResolution of symptomsLong-term therapyEarly detectionShortness of breathA-V blockHCQ therapyMagnetic resonance imagingPrompt discontinuationEndomyocardial biopsyPulmonary hypertensionEjection fractionHF therapyCardiac symptomsImprove patient outcomesSLE patientsSjogren's syndromeBeyond convention: non-compacted myocardium, ventricular tachycardia, and systolic dysfunction in dextrocardia patients: a case series
Nazarenko N, Maliha M, Cerna L, Abittan N, Borkowski P, Csecs I, Garcia M. Beyond convention: non-compacted myocardium, ventricular tachycardia, and systolic dysfunction in dextrocardia patients: a case series. Annals Of Medicine And Surgery 2025, 87: 56-61. PMID: 40109641, PMCID: PMC11918691, DOI: 10.1097/ms9.0000000000002855.Peer-Reviewed Original ResearchLeft ventricleDextrocardia patientsICD placementSeverely reduced ejection fractionHigh risk of sudden cardiac deathRight-sided pleural effusionRisk of sudden cardiac deathAbnormal myocardial developmentYears of follow-upNon-compacted myocardiumTreated with amiodaroneSubsegmental pulmonary embolismTreated with enoxaparinLong-term outcomesSudden cardiac deathSystolic dysfunctionEvent-freeWorsening dyspneaEjection fractionPulmonary embolismAtrial dilatationPleural effusionConduction abnormalitiesMedical therapyCase seriesCardiac MRI predicts mortality in patients with autoimmune rheumatic diseases
Csecs I, Tysarowski M, Baldassarre L, Feher A. Cardiac MRI predicts mortality in patients with autoimmune rheumatic diseases. Journal Of Cardiovascular Magnetic Resonance 2025, 27: 101317. DOI: 10.1016/j.jocmr.2024.101317.Peer-Reviewed Original Research
2024
Positron Emission Tomography in the Diagnosis and Management of Cardiac Allograft Vasculopathy
Csecs I, Yakkali S, Feher A. Positron Emission Tomography in the Diagnosis and Management of Cardiac Allograft Vasculopathy. Current Cardiovascular Imaging Reports 2024, 17: 85-92. DOI: 10.1007/s12410-024-09595-7.Peer-Reviewed Original ResearchManagement of CAVPositron emission tomography myocardial perfusion imagingCardiac allograft vasculopathyInvasive coronary angiographyMyocardial perfusion imagingMyocardial flow reservePositron emission tomographyHeart transplant recipientsMyocardial blood flowAllograft vasculopathyTransplant recipientsPET-derived MBFInternational Society for Heart and Lung Transplantation guidelinesCAV detectionAlternative to invasive coronary angiographyEfficacy of positron emission tomographyRoutine surveillance protocolEmission tomographyClass IIa indicationFrequent invasive proceduresReduce radiation exposurePositron emission tomography imagingPrognostic valueCoronary angiographyMulticenter studyIMPAIRED APICAL LONGITUDINAL STRAIN IS ASSOCIATED WITH ADVERSE EVENTS IN A MULTIETHNIC COHORT WITH APICAL HYPERTROPHIC CARDIOMYOPATHY
Csecs I, Lorenzatti D, Scotti A, Filtz A, Gongora C, Rodriguez C, Masri A, Moon J, Schenone A, Garcia M, Slipczuk L. IMPAIRED APICAL LONGITUDINAL STRAIN IS ASSOCIATED WITH ADVERSE EVENTS IN A MULTIETHNIC COHORT WITH APICAL HYPERTROPHIC CARDIOMYOPATHY. Journal Of The American College Of Cardiology 2024, 83: 1368. DOI: 10.1016/s0735-1097(24)03358-8.Peer-Reviewed Original ResearchHYDROXYCHLOROQUINE TROUBLES: THREE TOXIC TALES
Nazarenko N, Tauras J, Sims D, Shin J, Pullman J, Csecs I, Rochlani Y. HYDROXYCHLOROQUINE TROUBLES: THREE TOXIC TALES. Journal Of The American College Of Cardiology 2024, 83: 3580. DOI: 10.1016/s0735-1097(24)05570-0.Peer-Reviewed Original Research
2023
The fat and the flow: multiparametric imaging assessment of pericoronary adipose tissue and myocardial blood flow
Csecs I, Feher A. The fat and the flow: multiparametric imaging assessment of pericoronary adipose tissue and myocardial blood flow. Journal Of Nuclear Cardiology 2023, 30: 1570-1573. PMID: 36929294, DOI: 10.1007/s12350-023-03247-x.Peer-Reviewed Original ResearchCARDIOPULMONARY EXERCISE TESTING IS SAFE IN HYPERTROPHIC CARDIOMYOPATHY: INCIDENCE AND OUTCOMES OF SUSTAINED VENTRICULAR ARRHYTHMIAS IN A LARGE REFERRAL COHORT
Csecs I, Geske J, Garzona-Navas A, Klarich K, Ommen S, Allison T. CARDIOPULMONARY EXERCISE TESTING IS SAFE IN HYPERTROPHIC CARDIOMYOPATHY: INCIDENCE AND OUTCOMES OF SUSTAINED VENTRICULAR ARRHYTHMIAS IN A LARGE REFERRAL COHORT. Journal Of The American College Of Cardiology 2023, 81: 345. DOI: 10.1016/s0735-1097(23)00789-1.Peer-Reviewed Original ResearchRELATIONSHIP WITH INDUSTRY AND OTHER ENTITIES IN CURRENT CARDIOVASCULAR CLINICAL PRACTICE GUIDELINES
Csecs I, Abbott J, Thachil R, Kundu A, Chatterjee S, Sardar P, Faillace R. RELATIONSHIP WITH INDUSTRY AND OTHER ENTITIES IN CURRENT CARDIOVASCULAR CLINICAL PRACTICE GUIDELINES. Journal Of The American College Of Cardiology 2023, 81: 2292. DOI: 10.1016/s0735-1097(23)02736-5.Peer-Reviewed Original ResearchDoes Coronary Plaque Morphology Matter Beyond Plaque Burden?
Lorenzatti D, Piña P, Csecs I, Schenone A, Gongora C, Garcia M, Blaha M, Budoff M, Williams M, Dey D, Berman D, Virani S, Slipczuk L. Does Coronary Plaque Morphology Matter Beyond Plaque Burden? Current Atherosclerosis Reports 2023, 25: 167-180. PMID: 36808390, DOI: 10.1007/s11883-023-01088-0.Peer-Reviewed Original ResearchConceptsCoronary computed tomography angiographyMedical therapyPlaque burdenResponse to medical therapyPlaque analysisCoronary plaquesAssessment of coronary plaquesHigh-risk phenotypePreventive medical therapyAdverse cardiovascular eventsCoronary plaque featuresRandomized controlled trialsPericoronary inflammationMyocardial infarction typeCardiovascular eventsDisease progressionRisk phenotypesCulprit plaquesControlled trialsPlaque characteristicsPlaque featuresTherapySummaryThe identificationTracking disease progressionInfarct type